U.S. FDA Approves Ceterix Orthopaedics' NovoStitch Plus Meniscal Repair Device

Ceterix Orthopaedics, a California based medical device firm, received the U.S. Food and Drug Administration clearance for its new NovoStitch Plus meniscal repair device.

The device can allow doctors to reach the meniscus from various angles to make repair easier to perform. The system is used to place a circumferential compression stitch around the meniscus.

Featuring a pre-loaded suture implant, the device more than halves the number of steps required to use the device compared to the original model.

James Lee Pace, M.D., an orthopedic surgeon and director of the Sports Medicine Program at Children's Hospital Los Angeles in a statement said that the NovoStitch Plus meniscal repair system represents a significant improvement to one of the most innovative technologies developed for knee procedures in many years.

"The NovoStitch device has allowed me to preserve the meniscus for many of my patients, significantly reducing their likelihood of arthritis or a total knee replacement later in life. I am looking forward to incorporating the new device into my practice," Pace said.



Source: Medindia